1. Home
  2. OESX vs CASI Comparison

OESX vs CASI Comparison

Compare OESX & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OESX
  • CASI
  • Stock Information
  • Founded
  • OESX 1996
  • CASI 1991
  • Country
  • OESX United States
  • CASI China
  • Employees
  • OESX N/A
  • CASI N/A
  • Industry
  • OESX Building Products
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • OESX Consumer Discretionary
  • CASI Health Care
  • Exchange
  • OESX Nasdaq
  • CASI Nasdaq
  • Market Cap
  • OESX 19.3M
  • CASI 20.5M
  • IPO Year
  • OESX 2007
  • CASI 1996
  • Fundamental
  • Price
  • OESX $0.60
  • CASI $1.48
  • Analyst Decision
  • OESX Strong Buy
  • CASI Strong Buy
  • Analyst Count
  • OESX 2
  • CASI 1
  • Target Price
  • OESX $1.75
  • CASI $4.00
  • AVG Volume (30 Days)
  • OESX 92.3K
  • CASI 79.1K
  • Earning Date
  • OESX 08-06-2025
  • CASI 08-15-2025
  • Dividend Yield
  • OESX N/A
  • CASI N/A
  • EPS Growth
  • OESX N/A
  • CASI N/A
  • EPS
  • OESX N/A
  • CASI N/A
  • Revenue
  • OESX $79,720,000.00
  • CASI $31,368,000.00
  • Revenue This Year
  • OESX $7.16
  • CASI N/A
  • Revenue Next Year
  • OESX $16.23
  • CASI N/A
  • P/E Ratio
  • OESX N/A
  • CASI N/A
  • Revenue Growth
  • OESX N/A
  • CASI 8.39
  • 52 Week Low
  • OESX $0.55
  • CASI $1.09
  • 52 Week High
  • OESX $1.10
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • OESX 48.93
  • CASI 54.85
  • Support Level
  • OESX $0.59
  • CASI $1.21
  • Resistance Level
  • OESX $0.66
  • CASI $1.44
  • Average True Range (ATR)
  • OESX 0.03
  • CASI 0.11
  • MACD
  • OESX 0.00
  • CASI 0.03
  • Stochastic Oscillator
  • OESX 43.64
  • CASI 72.97

About OESX Orion Energy Systems Inc.

Orion Energy Systems Inc is a developer, manufacturer, and seller of lighting and energy management systems. The company segments include Orion Lighting Segment, Orion Maintenance Segment and Orion Electric Vehicle Charging Segment. It derives maximum revenue from Lighting Segment.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: